לקסיבה

Land: Israel

Sprog: hebraisk

Kilde: Ministry of Health

Aktiv bestanddel:

FOSAMPRENAVIR AS FOSAMPRENAVIR CALCIUM 700 MG

Tilgængelig fra:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC-kode:

J05AE07

Lægemiddelform:

TABLETS

Indgivelsesvej:

PER OS

Fremstillet af:

GLAXO WELLCOME OPERATION LTD, UK

Terapeutisk gruppe:

FOSAMPRENAVIR

Terapeutiske indikationer:

Lexiva is indicated in combination with other antiretroviral agents for the treatment of Human Immunodeficiency Virus (HIV) infection in adults. The following points should be considered when initiating therapy with Lexiva/ritonavir in protease inhibitor - experienced patients: - The protease inhibitor - experienced patient study was not large enough to reach a definitive conclusion that Lexiva/ritonavir and lopinavir/ritonavir are clinically equivalent. - Once - daily administration of Lexiva plus ritonvir is not recommended for proteaseinhibitor-experienced patients.

Autorisation dato:

2009-10-01